Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Progress in somatic gene therapy].

Jacob Giehm Mikkelsen1, Thomas Gryesten Jensen

  • 1Stanford University School of Medicine, Departments of Pediatrics and Genetics, USA.

Ugeskrift for Laeger
|March 29, 2003
PubMed
Summary

Gene therapy offers a promising alternative to traditional treatments, but requires better vector efficiency and production. Recent advancements focus on improved vectors and non-viral methods for clinical gene transfer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AAV vector production in suspension cells using PEI transfection and sodium butyrate with orthogonal assessment of function and quality.

Molecular therapy. Advances·2026
Same author

PKP1 promotes lung cancer by modulating energy metabolism through stabilization of PFKP.

Biomarker research·2025
Same author

CXCR2 deficiency with myelokathexis caused by a novel variant: correction via CRISPR/Cas9.

Haematologica·2025
Same author

Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticles.

Nucleic acids research·2025
Same author

Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease.

Nature communications·2025
Same author

Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cells.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Context:

  • Gene therapy presents a novel therapeutic strategy.
  • Current treatments face limitations, driving the need for alternatives.
  • Animal studies show promise, but clinical translation is pending.

Purpose:

  • To review recent progress in somatic gene therapy.
  • To focus on advancements in vector development.
  • To highlight current examples of clinical efficiency.

Summary:

  • Therapeutic gene transfer is an alternative to current treatments.
  • Key developments include high-capacity, low-immunogenicity vectors, hybrid vectors, site-specific integration, RNA interference, and efficient non-viral gene transfer.
  • Improved vector efficiency and large-scale production are crucial for widespread clinical application.

Impact:

  • Advances in vector technology are essential for the clinical success of gene therapy.
  • Enhanced vector efficiency and production methods will accelerate the adoption of gene therapy.
  • This review provides insights into the evolving landscape of somatic gene therapy and its clinical potential.

Related Experiment Videos